Efficiently converting invisible light while allowing full visible light transmission is key to achieving high‐performance semitransparent organic photovoltaics (ST‐OPVs). Here, a detailed balance strategy is explored to optimize the ST‐OPV via taking both absorption and carrier dynamics into consideration. Based on this principle, comprehensive optimizations are carried out, including a ternary strategy, donor:acceptor blend ratio, thickness, antireflection, etc., to compromise the invisible energy conversion and visible transmission for high‐performance ST‐OPVs. As a result, the opaque OPV device exhibits a champion power conversion efficiency of 19.35% (certificated 19.07%), and most strikingly, the best ST‐OPV shows a remarkably high light‐utilization efficiency of 5.0%, where the efficiency and the average visible transmission are 12.95% and 38.67%, respectively. An efficiency of 12.09% is achieved on the upscaled device with an area of 1.05 cm2, demonstrating its promise for large‐area fabrication. These results are among the best values for ST‐OPVs. Besides, it is demonstrated that the ST‐OPV exhibits good infrared light‐reflection capability for thermal control. This work provides a rational design of balancing the absorbing selectivity and photon‐to‐electron conversion for high‐performance ST‐OPVs, and may pave the way toward the practical application of solar windows.
Perovskite/organic tandem solar cells (TSCs) have attracted increasing attention owing to their potential for high performance solution processable photovoltaics. However, Br/I mixed-halide perovskites as the active of wide band gap...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.